Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05805462 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Euro-CRAFT Registry

Study acronym: Euro-CRAFT
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 12, 2026 (before its estimated September 22, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 19 of 19 sites
    v3
  2. Primary completion date: Sep 22, 2025 to Sep 22, 2026v2 Show 6 more changesShow less
    • Primary endpoint revised
    • Enrollment target: 700 to 671
    • Study sites: 3 to 19
    • Study completion date: Sep 22, 2029 to Sep 22, 2030
    • Eligibility criteria expanded, about 102 words
    • Secondary endpoints: 8 to 6
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Euro-CRAFT Registry is a prospective, multicentric, international registry of patients undergoing functional assessment of the coronary microcirculation using the continuous thermodilution technique. Angina and quality of life questionnaires (Seattle Angina Questionnaire 19 - SAQ19, ORBITA app) will be obtained at baseline, at 6 months, and 1-year follow-up. Clinical follow-up will be performed at 1 year (optionally until 5 years).
Trial Details
NCT Number NCT05805462
Lead Sponsor CoreAalst BV
Collaborators: Hexacath, France
Conditions
(from sponsor)		 Coronary Microvascular Disease
Related terms Microvascular Angina
Enrollment 671 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov